Verdence Capital Advisors LLC Merck & Co., Inc. Transaction History

Verdence Capital Advisors LLC

$1.23 Billion
Q3 2024

A detailed history of Verdence Capital Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 56,079 shares of MRK stock, worth $5.58 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

56,079

Previous 54,848 2.24%

Holding current value

$5.58 Million

Previous $6.79 Million 6.22%

% of portfolio

0.52%

Previous 0.62%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$111.15 - $128.97 $136,825 - $158,762	1,231 Added 2.24%	56,079 $6.37 Million
Q2 2024 Jul 25, 2024	BUY	$123.8 - $132.96 $138,656 - $148,915	1,120 Added 2.08%	54,848 $6.79 Million
Q1 2024 Apr 25, 2024	BUY	$113.24 - $131.95 $1,358 - $1,583	12 Added 0.02%	53,728 $7.09 Million
Q4 2023 Jan 31, 2024	SELL	$100.18 - $109.02 $2,203 - $2,398	-22 Reduced 0.04%	53,716 $5.86 Million
Q3 2023 Oct 25, 2023	BUY	$102.95 - $114.33 $344,676 - $382,776	3,348 Added 6.64%	53,738 $5.53 Million
Q2 2023 Jul 28, 2023	SELL	$108.61 - $118.38 $1,629 - $1,775	-15 Reduced 0.03%	50,390 $5.81 Million
Q1 2023 Apr 24, 2023	SELL	$102.94 - $114.86 $536,935 - $599,109	-5,216 Reduced 9.38%	50,405 $5.36 Million
Q4 2022 Jan 20, 2023	SELL	$87.44 - $112.11 $248,591 - $318,728	-2,843 Reduced 4.86%	55,621 $0
Q3 2022 Nov 15, 2022	SELL	$84.53 - $94.96 $98,561 - $110,723	-1,166 Reduced 1.96%	58,464 $5.04 Million
Q2 2022 Aug 08, 2022	SELL	$83.49 - $94.64 $688,208 - $780,117	-8,243 Reduced 12.14%	59,630 $5.44 Million
Q1 2022 May 02, 2022	SELL	$73.51 - $82.4 $2.01 Million - $2.25 Million	-27,345 Reduced 28.72%	67,873 $5.57 Million
Q4 2021 Jan 26, 2022	SELL	$72.28 - $90.54 $813,222 - $1.02 Million	-11,251 Reduced 10.57%	95,218 $7.3 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $854,067 - $939,259	11,915 Added 12.6%	106,469 $8 Million
Q2 2021 Aug 06, 2021	BUY	$70.31 - $77.77 $2.32 Million - $2.56 Million	32,942 Added 53.47%	94,554 $7.35 Million
Q1 2021 May 11, 2021	BUY	$68.86 - $81.11 $104,460 - $123,043	1,517 Added 2.52%	61,612 $4.75 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $935,234 - $1.04 Million	13,031 Added 27.69%	60,095 $4.92 Million
Q3 2020 Nov 09, 2020	BUY	$73.18 - $82.95 $56,348 - $63,871	770 Added 1.66%	47,064 $3.9 Million
Q2 2020 Aug 11, 2020	BUY	$70.42 - $80.13 $437,026 - $497,286	6,206 Added 15.48%	46,294 $3.58 Million
Q1 2020 May 13, 2020	BUY	$63.36 - $87.82 $404,616 - $560,818	6,386 Added 18.95%	40,088 $3.08 Million
Q4 2019 Feb 03, 2020	BUY	$77.58 - $87.54 $32,738 - $36,941	422 Added 1.27%	33,702 $3.07 Million
Q3 2019 Mar 06, 2020	SELL	$76.08 - $82.93 $59,342 - $64,685	-780 Reduced 2.29%	33,280 $2.8 Million
Q2 2019 Mar 02, 2020	SELL	$69.84 - $81.59 $545,729 - $637,544	-7,814 Reduced 18.66%	34,060 $2.86 Million
Q1 2019 Mar 02, 2020	SELL	$69.58 - $79.36 $397,301 - $453,145	-5,710 Reduced 12.0%	41,874 $3.48 Million
Q4 2018 Feb 25, 2020	SELL	$65.24 - $75.71 $42,862 - $49,741	-657 Reduced 1.36%	47,584 $3.64 Million
Q3 2018 Feb 25, 2020	BUY	$57.69 - $67.84 $2.18 Million - $2.56 Million	37,793 Added 361.72%	48,241 $3.42 Million
Q2 2018 Feb 11, 2020	SELL	$50.83 - $59.72 $849,470 - $998,040	-16,712 Reduced 61.53%	10,448 $634,000
Q1 2018 Jan 30, 2020	BUY	$50.96 - $59.23 $198,183 - $230,345	3,889 Added 16.71%	27,160 $1.48 Million
Q4 2017 Jan 30, 2020	BUY	$51.62 - $61.64 $1.2 Million - $1.43 Million	23,271	23,271 $1.31 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.

Account

Verdence Capital Advisors LLC Merck & Co., Inc. Transaction History